IBDEI0Y3 ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16004,1,2,0)
 ;;=2^99244
 ;;^UTILITY(U,$J,358.3,16005,0)
 ;;=99245^^60^714^5
 ;;^UTILITY(U,$J,358.3,16005,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,16005,1,1,0)
 ;;=1^Comprehensive, High
 ;;^UTILITY(U,$J,358.3,16005,1,2,0)
 ;;=2^99245
 ;;^UTILITY(U,$J,358.3,16006,0)
 ;;=99024^^60^715^1
 ;;^UTILITY(U,$J,358.3,16006,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,16006,1,1,0)
 ;;=1^Post-Op Follow-up Visit
 ;;^UTILITY(U,$J,358.3,16006,1,2,0)
 ;;=2^99024
 ;;^UTILITY(U,$J,358.3,16007,0)
 ;;=D61.1^^61^716^7
 ;;^UTILITY(U,$J,358.3,16007,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16007,1,3,0)
 ;;=3^Anemia,Aplastic,Drug-Induced
 ;;^UTILITY(U,$J,358.3,16007,1,4,0)
 ;;=4^D61.1
 ;;^UTILITY(U,$J,358.3,16007,2)
 ;;=^5002336
 ;;^UTILITY(U,$J,358.3,16008,0)
 ;;=D61.2^^61^716^6
 ;;^UTILITY(U,$J,358.3,16008,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16008,1,3,0)
 ;;=3^Anemia,Aplastic d/t External Agents
 ;;^UTILITY(U,$J,358.3,16008,1,4,0)
 ;;=4^D61.2
 ;;^UTILITY(U,$J,358.3,16008,2)
 ;;=^5002337
 ;;^UTILITY(U,$J,358.3,16009,0)
 ;;=D61.89^^61^716^9
 ;;^UTILITY(U,$J,358.3,16009,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16009,1,3,0)
 ;;=3^Anemia,Aplastic/Bone Marrow Failure Syndromes
 ;;^UTILITY(U,$J,358.3,16009,1,4,0)
 ;;=4^D61.89
 ;;^UTILITY(U,$J,358.3,16009,2)
 ;;=^5002341
 ;;^UTILITY(U,$J,358.3,16010,0)
 ;;=D61.9^^61^716^8
 ;;^UTILITY(U,$J,358.3,16010,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16010,1,3,0)
 ;;=3^Anemia,Aplastic,Unspec
 ;;^UTILITY(U,$J,358.3,16010,1,4,0)
 ;;=4^D61.9
 ;;^UTILITY(U,$J,358.3,16010,2)
 ;;=^5002342
 ;;^UTILITY(U,$J,358.3,16011,0)
 ;;=D59.0^^61^716^10
 ;;^UTILITY(U,$J,358.3,16011,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16011,1,3,0)
 ;;=3^Anemia,Drug-Induced Autoimmune Hemolytic
 ;;^UTILITY(U,$J,358.3,16011,1,4,0)
 ;;=4^D59.0
 ;;^UTILITY(U,$J,358.3,16011,2)
 ;;=^5002323
 ;;^UTILITY(U,$J,358.3,16012,0)
 ;;=D62.^^61^716^20
 ;;^UTILITY(U,$J,358.3,16012,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16012,1,3,0)
 ;;=3^Anemia,Posthemorrhagic,Acute
 ;;^UTILITY(U,$J,358.3,16012,1,4,0)
 ;;=4^D62.
 ;;^UTILITY(U,$J,358.3,16012,2)
 ;;=^267986
 ;;^UTILITY(U,$J,358.3,16013,0)
 ;;=D64.81^^61^716^1
 ;;^UTILITY(U,$J,358.3,16013,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16013,1,3,0)
 ;;=3^Anemia d/t Antineoplastic Chemotherapy
 ;;^UTILITY(U,$J,358.3,16013,1,4,0)
 ;;=4^D64.81
 ;;^UTILITY(U,$J,358.3,16013,2)
 ;;=^5002349
 ;;^UTILITY(U,$J,358.3,16014,0)
 ;;=D63.1^^61^716^4
 ;;^UTILITY(U,$J,358.3,16014,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16014,1,3,0)
 ;;=3^Anemia in Chr Kidney Disease
 ;;^UTILITY(U,$J,358.3,16014,1,4,0)
 ;;=4^D63.1
 ;;^UTILITY(U,$J,358.3,16014,2)
 ;;=^332908
 ;;^UTILITY(U,$J,358.3,16015,0)
 ;;=D63.0^^61^716^5
 ;;^UTILITY(U,$J,358.3,16015,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16015,1,3,0)
 ;;=3^Anemia in Neoplastic Disease
 ;;^UTILITY(U,$J,358.3,16015,1,4,0)
 ;;=4^D63.0
 ;;^UTILITY(U,$J,358.3,16015,2)
 ;;=^321978
 ;;^UTILITY(U,$J,358.3,16016,0)
 ;;=D63.8^^61^716^3
 ;;^UTILITY(U,$J,358.3,16016,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16016,1,3,0)
 ;;=3^Anemia in Chr Diseases Classified Elsewhere
 ;;^UTILITY(U,$J,358.3,16016,1,4,0)
 ;;=4^D63.8
 ;;^UTILITY(U,$J,358.3,16016,2)
 ;;=^5002343
 ;;^UTILITY(U,$J,358.3,16017,0)
 ;;=D51.8^^61^716^27
 ;;^UTILITY(U,$J,358.3,16017,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16017,1,3,0)
 ;;=3^Anemia,Vitamin B12 Deficiency
 ;;^UTILITY(U,$J,358.3,16017,1,4,0)
 ;;=4^D51.8
 ;;^UTILITY(U,$J,358.3,16017,2)
 ;;=^5002288
 ;;^UTILITY(U,$J,358.3,16018,0)
 ;;=D51.1^^61^716^2
 ;;^UTILITY(U,$J,358.3,16018,1,0)
 ;;=^358.31IA^4^2
